Category: 6. Health

A GROUNDBREAKING study demonstrates that cross-frequency transcranial alternative brain stimulation (cf-tACS) can enhance visual recovery in stroke patients by boosting perceptual training and restoring motion processing.

Innovative Approach…

Introduction

Hypertension is a serious medical illness and a major global risk factor, affecting around 1.28 billion individuals aged 30–79 worldwide and contributing significantly to premature mortality. Among them, over 588 million (46%) are…

Pertussis, or whooping cough, remains a highly contagious respiratory infection caused by Bordetella pertussis. Despite inclusion of pertussis vaccines in immunization programs since the 1970s, outbreaks have re-emerged globally due…

Introduction

Chronic pelvic pain (CPP) is defined as pain located within the pelvic region involving the anatomical pelvic cavity, abdomen below the umbilicus, perineum, lumbosacral back, and buttocks, and typically persists over six months.^1,2…

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood and bone…

Introduction

Kidney stone disease (KSD) is a highly prevalent condition worldwide, representing one of the most common urological diseases, with reported incidence rates ranging from approximately 1% in parts of Asia to as high as 13% in North…

An AI tool that can analyze abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukemia are diagnosed.

Researchers have created…

Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications. Now, researchers at University of California San Diego and their colleagues have developed a…

In a prospective, observational study, researchers did not identify any new safety signals with long-term use of vedolizumab for patients with inflammatory bowel disease (IBD).

This prospective, observational, multicenter cohort study included…